Indeed, inhibiting IL-12/IL-23 signaling either by the administration of an IL-12p40–neutralizing antibody or genetic ablation of IL-12/IL-23 subunits ameliorates Aβ pathology and cognitive impairment in APP/PS1 mice [28]. Here, APP is linked to Cognitive impairment.